Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma. 1987

K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
University of Louisville, Kentucky.

Twenty-four patients with bilateral chronic open-angle glaucoma received three treatments: (1) artificial tears (control) in both eyes, (2) artificial tears in one eye and one drop of timolol (0.05%) in the other, and (3) artificial tears in one eye and one drop of betaxolol (0.05%) in the other. Twelve patients always received the test medication in the left eye and 12 in the right eye. The patients were examined and questioned about ocular symptoms at the time of drug administration and at 1, 5, 30, and 60 minutes. Irritation was noted in five treated eyes after artificial tears, in three after timolol, and in 11 after betaxolol. The incidence of irritation after initial treatment was significantly lower than expected for timolol than for artificial tears or betaxolol (P less than 0.01).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005123 Eye The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light. Eyes
D005260 Female Females
D005902 Glaucoma, Open-Angle Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris. Glaucoma Simplex,Glaucoma, Pigmentary,Glaucoma, Simple,Open-Angle Glaucoma,Chronic Primary Open Angle Glaucoma,Glaucoma, Compensated,Glaucoma, Compensative,Glaucoma, Open Angle,Glaucoma, Primary Open Angle,Glaucoma, Secondary Open Angle,Primary Open Angle Glaucoma,Secondary Open Angle Glaucoma,Compensated Glaucoma,Compensative Glaucoma,Open Angle Glaucoma,Open Angle Glaucomas,Open-Angle Glaucomas,Pigmentary Glaucoma,Simple Glaucoma,Simplex, Glaucoma,Simplices, Glaucoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
April 1988, Acta ophthalmologica,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
January 2003, Japanese journal of ophthalmology,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
August 1998, Journal of glaucoma,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
April 1981, Indian journal of ophthalmology,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
March 1982, Bulletin des societes d'ophtalmologie de France,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
May 1986, American journal of ophthalmology,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
October 1979, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
January 1982, Bulletin des societes d'ophtalmologie de France,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
January 1981, Duodecim; laaketieteellinen aikakauskirja,
K Kendall, and T Mundorf, and G Nardin, and T J Zimmerman, and R Hesse, and P Lavin
June 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics,
Copied contents to your clipboard!